Pravin S Shirude

This inventor holds 11 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignees: Cv6 Therapeutics (Ni) Limited, University of Southern California. Active years: 2020-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pravin S Shirude. Retrieved from https://idiyas.com/inventor/pravin-s-shirude

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 (Patent Applications = 4)

% Patents Active = 90.9

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 1 (Patent Applications = 3)

Average Co-Inventor Count = 2.3

ph-index = 5

Forward Citations = 82(Granted Patents)

Location History:

Pune, IN (2020 - 2021)
Maharashtra, IN (2020 - 2023)

Company Filing History:

11 out of 18

Cv6 Therapeutics (Ni) Limited

patents

4 out of 1,694

University of Southern California

patents

where one patent can have more than one assignee

Years Active: 2020-2024

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12098133 - Hydantoin containing deoxyuridine triphosphatase inhibitors (2024-09-24),

2. 11584723 - Hydantoin containing deoxyuridine triphosphatase inhibitors (2023-02-21),

3. 11479531 - Deoxyuridine triphosphatase inhibitors (2022-10-25),

4. 11198677 - Deoxyuridine triphosphatase inhibitors containing amino sulfonyl linkage (2021-12-14),

5. 11124485 - Deoxyuridine triphosphatase inhibitors containing cyclopropano linkage (2021-09-21),

6. 11104649 - Hydantoin containing deoxyuridine triphosphatase inhibitors (2021-08-31),

7. 10577321 - Deoxyuridine triphosphatase inhibitors (2020-03-03),

8. 10570100 - Deoxyuridine triphosphatase inhibitors containing amino sulfonyl linkage (2020-02-25),

9. 10570098 - Hydantoin containing deoxyuridine triphosphatase inhibitors (2020-02-25),

10. 10562860 - Hydantoin containing deoxyuridine triphosphatase inhibitors (2020-02-18),

11. 10544105 - Deoxyuridine triphosphatase inhibitors containing cyclopropano linkage (2020-01-28),

Title: The Innovations of Pravin S Shirude: A Pioneer in dUTPase Inhibitor Research

Introduction

Pravin S Shirude, an accomplished inventor based in Maharashtra, India, has made significant contributions to the field of biochemistry through his innovative work in deoxyuridine triphosphatase (dUTPase) inhibitors. With a remarkable portfolio of 11 patents, Shirude has become a notable figure in the scientific community, advancing our understanding of nucleotide metabolism and its implications in therapeutic applications.

Latest Patents

Among his latest patents, Shirude has developed innovative dUTPase inhibitors that include compositions comprising these compounds along with methods for their use. His work focuses on hydantoin-containing dUTPase inhibitors, which play a crucial role in inhibiting the dUTPase enzyme. These advancements signify promising avenues for medical research and potential therapeutic interventions in various diseases.

Career Highlights

Throughout his career, Pravin S Shirude has held key positions in prestigious institutions like Cv6 Therapeutics Limited and the University of Southern California. His roles in these organizations have contributed greatly to his expertise in both research and application of biochemical innovations.

Collaborations

Shirude has collaborated with notable professionals in the field, such as Mark Spyvee and Robert D Ladner. These collaborations have enriched his research initiatives and allowed for a multidisciplinary approach to tackling complex biochemical challenges, enhancing the impact of his innovations.

Conclusion

Pravin S Shirude stands out as a leading inventor in the realm of dUTPase inhibitor research. His continuous pursuit of excellence and innovation in biochemistry not only highlights the importance of his work but also paves the way for future developments in therapeutic strategies. With his impressive track record of patents and collaborations, Shirude exemplifies the spirit of innovation that drives the scientific community forward.

Profile summary based on public USPTO records.